Ligand validation:1NJJ

ORX: N~2~-({3-HYDROXY-2-METHYL-5-[(PHOSPHONOOXY)METHYL]PYRIDIN-4-YL}METHYL)-D-ORNITHINE

ORX is a Ligand Of Interest in 1NJJ designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
1NJJ_ORX_B_603	68%	1%	0.152	0.965	2.81	4.46	9	14	3	0	100%	1
1NJJ_ORX_A_602	53%	1%	0.189	0.953	2.92	4.44	9	14	1	0	100%	1
1NJJ_ORX_C_604	43%	2%	0.19	0.914	2.52	4.57	8	15	1	0	100%	1
1NJJ_ORX_D_426	41%	1%	0.212	0.926	2.74	4.41	11	16	2	1	100%	1
1SZR_ORX_B_571	70%	37%	0.112	0.93	0.97	1.47	2	7	2	0	100%	1
8D5R_ORX_A_502	92%	23%	0.084	0.974	1.98	1.22	6	3	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.